Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, et al. (2008) Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70: 1630–1635.
[2]
Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanp？？ M, et al. (2004) EFNS guidelines on neuropathic pain assessment. Eur J Neurol 11: 153–162.
[3]
Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakigi R, et al. (2008) Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119: 1705–1719.
[4]
Garcia-Larrea L, Convers P, Magnin M, André-Obadia N, Peyron R, et al. (2002) Laser-evoked potential abnormalities in central pain patients: The influence of spontaneous and provoked pain. Brain 125: 2766–2781.
[5]
Treede RD, Lorenz J, Baumg？rtner U (2003) Clinical usefulness of laser-evoked potentials. Neurophysiol Clin 33: 303–314.
[6]
Truini A, Galeotti F, Haanpaa M, Zucchi R, Albanesi A, et al. (2008) Pathophysiology of pain in postherpetic neuralgia: A clinical and neurophysiological study. Pain 140: 405–410.
[7]
Granovsky Y, Matre D, Sokolik A, Lorenz J, Casey KL (2005) Thermoreceptive innervation of human glabrous and hairy skin: A contact heat evoked potential analysis. Pain 115: 238–247.
[8]
Lauria G, Cornblath DR, Johansson O, McArthur JC, Mellgren SI, et al. (2005) EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 12: 747–758.
[9]
England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, et al. (2009) Evaluation of distal symmetric polyneuropathy: The role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 39: 106–115.
[10]
Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, et al. (2007) Using screening tools to identify neuropathic pain. Pain 127: 199–203.
[11]
Krause SJ, Backonja MM (2003) Development of a neuropathic pain questionnaire. Clin J Pain 19: 306–314.
[12]
Portenoy R (2006) Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 22: 1555–1565.
[13]
Freynhagen R, Baron R, Gockel U, Tolle T (2006) painDETECT: A new screening questionnaire to detect neuropathic components in patients with back pain. Curr Med Res Opin 22: 1911–1920.
[14]
Bennett MI (2001) The LANSS Pain Scale: The Leeds Assessment of Neuropathic Symptoms and Signs. Pain 92: 147–157.
[15]
Bouhassira D, Attal N, Alchaar H, Boureau F, Bruxelle J, et al. (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114: 29–36.
[16]
Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, et al. (2009) A novel tool for the assessment of pain: Validation in low back pain. PLoS Med 6(4): e1000047. doi:10.1371/journal.pmed.1000047.
[17]
Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, et al. (2008) Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138: 343–353.
[18]
Baron R (2008) Mechanisms of postherpetic neuralgia—We are hot on the scent. Pain 140: 395–396.
[19]
Hansson P, Haanp？？ M (2007) Diagnostic work-up of neuropathic pain: Computing, using questionnaires or examining the patient? Eur J Pain 11: 367–369.
[20]
Svendsen KB, Jensen TS, Hansen HJ, Bach FW (2005) Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114: 473–481.
